Research

Mayo Clinic is building toward a future when biologics can cure cancer, kidney disease and diabetes. Mayo marks 2022 as a year of significant strides ...

Athletes with a genetic heart disease are often disqualified from participating in competitive sports because of the perceived risk of sudden cardiac arrest. While the clinicians' intent may ...

The National Institutes of Health's (NIH) All of Us Research Program has begun returning personalized health-related DNA results to more than 155,000 participants. The reports detail whether participants ...

Could prescribing specific nutrients, grains, fruits and vegetables tailored to a person's DNA and other biological characteristics help improve their health? Precision nutrition took center stage ...

Mayo Clinic researchers found a noncellular substance suggested improvement in restoring muscle function and bladder control in preclinical models. The teams of Atta Behfar, M.D., Ph.D. and Emanuel ...

Mayo Clinic researchers replicated chronic dry mouth from radiation damage in preclinical models, laying the foundation for stem cell research to regenerate salivary tissue after ...

During the first months of the COVID-19 pandemic, clinicians across Mayo Clinic transitioned to virtual modes of care to continue to treat patients safely — ...

At Mayo Clinic, the Department of Business Development is the front door to business. From technology commercialization to strategic partnerships, the ultimate goal of innovation ...

Mayo Clinic researchers and collaborators have identified key clinical findings that can help clinicians recognize patients with potentially treatable causes of rapidly progressive dementia, who ...

A new Mayo Clinic study finds 1 in 6 people with pancreatic cancer harbor inherited genetic mutations. Identifying hereditary gene mutations in pancreatic cancer can help ...

Thanksgiving Day marks Family Health History Day, an annual national public health campaign to encourage people to better understand what health characteristics run in their ...

In a new study published in Circulation: Genomics & Precision Medicine, Mayo Clinic researchers designed and developed the first suppression-replacement KCNH2 gene therapy for correcting both long QT syndrome ...